Acute Hypoxemic Respiratory Failure

PaO2 <60 mmHg or SpO2 <90% on room air — multifactorial; identify and treat the dominant cause while supporting oxygenation

Symptoms / Associated Sx

  • Dyspnea, tachypnea, use of accessory muscles

  • Hypoxia — SpO2 <90% or PaO2 <60 mmHg on room air

  • Agitation, confusion, altered mentation (cerebral hypoxia)

  • Tachycardia, diaphoresis, cyanosis

  • Cause-specific: crackles (CHF/pneumonia), wheeze (COPD/asthma), absent breath sounds (pneumothorax/effusion), pleuritic pain (PE/pleuritis)

Denies

  • Fever + consolidation (rules out pneumonia as sole cause if absent)

  • Leg edema + JVD + elevated BNP (rules out CHF as dominant cause)

  • Prior COPD or heavy smoking (rules out obstructive component)

  • Recent immobility + leg swelling (rules out PE if truly absent)

Social History (SHx)

Prior cardiopulmonary history (COPD, CHF, ILD, PE), smoking, immunosuppression, recent surgery or immobility (PE risk), malignancy, autoimmune disease, recent infections or sick contacts, home O2 use.

Main Etiology

  • Pneumonia (most common — viral or bacterial; V/Q mismatch)

  • Acute decompensated heart failure / pulmonary edema (hydrostatic or cardiogenic)

  • COPD or asthma exacerbation

  • Pulmonary embolism (V/Q mismatch → dead space)

  • ARDS (diffuse alveolar damage; any cause — sepsis, pneumonia, aspiration, trauma)

  • ILD exacerbation (fibrotic lung; impaired diffusion)

  • Pleural effusion (large compressive)

  • Pneumothorax

Most Common DDx

  • CHF / cardiogenic pulmonary edema (bilateral crackles; BNP elevated; edema; JVD; responds to diuretics + vasodilators; CXR shows bilateral interstitial infiltrates + cardiomegaly + Kerley B lines)

  • Pneumonia (fever; consolidation on CXR; leukocytosis; elevated procalcitonin; responds to antibiotics)

  • Pulmonary embolism (acute onset; pleuritic pain; tachycardia; Wells score + D-dimer + CTPA; no consolidation early; ECG right heart strain)

  • ARDS (bilateral diffuse infiltrates; PaO2/FiO2 <300; no cardiogenic cause; acute onset within 1 week of insult)

  • ILD exacerbation (known ILD or new diffuse fibrosis on CT; ground-glass opacities; no infection identified; prior autoimmune or occupational history)

  • Pneumothorax (sudden onset; decreased unilateral breath sounds; hyperresonance; CXR or point-of-care ultrasound — lung sliding absent)

DATA

  • ABG (PaO2, PaCO2, pH — type of failure; P/F ratio = PaO2/FiO2 for ARDS criteria; A-a gradient)

  • SpO2 continuous monitoring

  • CBC, BMP, LFTs, procalcitonin, blood cultures

  • BNP/NT-proBNP (CHF vs. non-cardiogenic)

  • Troponin (ACS, RV strain from PE)

  • D-dimer (PE screening if low-intermediate pre-test probability)

  • CXR (pattern — lobar: pneumonia; bilateral symmetric: CHF/ARDS; unilateral: effusion/pneumothorax)

  • CT pulmonary angiography (PE; also characterizes parenchyma)

  • Point-of-care ultrasound (POCUS) — lung sliding (pneumothorax), B-lines (CHF/pulmonary edema), effusion, RV dilation (PE)

  • Echo (RV strain, LV function, wall motion)

  • EKG (right heart strain, sinus tachycardia, arrhythmia)

  • Respiratory viral panel; Legionella + pneumococcal urine antigens

Home Meds

  • Diuretics (CHF component — assess current dose)

  • Inhalers (COPD/asthma — continue; escalate)

  • Immunosuppressants (ILD — assess; may need to continue or modify)

  • Anticoagulants (PE — assess compliance; dose)

Plan

  • Immediate: airway assessment and O2 support

    • Low-flow NC 1–6 L/min (mild hypoxia)

    • High-flow nasal cannula (HFNC): up to 60 L/min flow + FiO2 titrated; first-line for moderate-severe hypoxemic respiratory failure; reduces intubation rate in ARDS/viral pneumonia

    • BiPAP (non-invasive): COPD, CHF, OHS — improves V/Q mismatch and reduces work of breathing

    • Intubation: SpO2 <88% despite HFNC at max settings; altered mentation; hemodynamic instability; inability to protect airway

  • Treat the dominant underlying cause:

    • Pneumonia → antibiotics per CAP/HAP protocol

    • CHF → IV furosemide 40–80 mg IV; IV nitroglycerin if BP permits

    • COPD → bronchodilators + steroids + antibiotics

    • PE → anticoagulation ± thrombolysis (see PE section)

    • Pneumothorax → needle decompression/chest tube (see pneumothorax section)

  • IV access; continuous monitoring (telemetry, pulse oximetry, ABG q2–4h)

  • Positioning: HOB 30–45°; prone positioning if ARDS + P/F <150

  • DVT prophylaxis; stress ulcer prophylaxis (if intubated)

  • ICU if: progressive hypoxia despite initial therapy, O2 requirement >50% FiO2, hemodynamic instability, altered mentation

  • Pulmonology + critical care consult; relevant subspecialty per etiology

  • Daily CBC, BMP, ABG; trend procalcitonin; fever curve; culture follow-up

  • PT/OT early; aspiration precautions if at risk

  • Discharge: Address underlying cause; supplemental O2 if SpO2 <88% on exertion; pulmonology follow-up; repeat imaging if needed; education on worsening symptoms

Red Flags

  • SpO2 <88% despite 15L NRB → HFNC immediately; prepare for BiPAP/intubation

  • Rapidly increasing O2 requirement over 1–2h → impending respiratory failure → ICU; consider early intubation

  • Tension pneumothorax (tracheal deviation + hemodynamic instability + absent breath sounds) → needle decompression immediately; do not wait for CXR

  • Massive PE + hypoxic respiratory failure → systemic tPA or CDT; ICU

  • ARDS (P/F ratio <200) → lung-protective ventilation (6 mL/kg IBW; plateau pressure <30 cmH2O); prone positioning ≥12h/day

Senior IM Resident Pearls

  • A-a gradient = PAO2 − PaO2; normal ~10–15 mmHg (increases with age); elevated A-a gradient with hypoxia = V/Q mismatch or diffusion impairment (pneumonia, CHF, PE, ARDS); normal A-a gradient + hypoxia = hypoventilation (COPD, neuromuscular, opioids)

  • HFNC superiority over standard O2 in hypoxemic respiratory failure (FLORALI trial) — reduces intubation rates in non-hypercapnic patients; does not benefit hypercapnic patients (use BiPAP instead)

  • POCUS is the fastest bedside tool for differentiating CHF (B-lines bilateral) vs. pneumothorax (absent lung sliding) vs. effusion vs. consolidation — available faster than portable CXR

  • P/F ratio: PaO2 ÷ FiO2; normal ~450–500; <300 = ARDS; <200 = moderate ARDS; <100 = severe ARDS; quick severity assessment

  • Common mistake: Delaying HFNC trial in favor of standard face mask — HFNC dramatically improves oxygenation and should be escalated early before respiratory fatigue sets in

Acute Hypoxemic Respiratory Failure — Rapid Recall

Presentation

Dyspnea + tachypnea + SpO₂ <90%

  • Accessory muscle use

  • Tachycardia

  • Confusion/agitation (late)

  • Cyanosis (very late)

Key Findings → Likely Diagnosis

  • Crackles + JVD + edema + BNP ↑ → CHF

  • Fever + leukocytosis + consolidation → Pneumonia

  • Sudden dyspnea + pleuritic CP + tachycardia → PE

  • Diffuse bilateral infiltrates + severe hypoxia → ARDS

  • Wheezing + smoking history + hypercapnia → COPD

  • Absent unilateral breath sounds + no lung sliding → Pneumothorax

Key Labs

  • ABG: PaO₂ <60 confirms hypoxemia

  • BNP ↑: CHF

  • Troponin ↑: ACS/RV strain

  • Procalcitonin ↑: Bacterial pneumonia

  • D-dimer ↑: Screen for PE

Key Imaging

  • CXR bilateral edema → CHF

  • CXR focal infiltrate → Pneumonia

  • CTPA filling defect → PE

  • Diffuse bilateral infiltrates → ARDS

  • Absent lung sliding on POCUS → PTX

Confirmatory Test

  • CHF → Echo

  • PE → CTPA

  • PTX → POCUS/CXR

  • ARDS → P/F <300 + Berlin Criteria

First-Line Management

SpO₂ <90%
→ O₂ supplementation

Moderate-Severe Hypoxia
→ HFNC up to 60 L/min

Hypercapnia (PaCO₂ >45)
→ BiPAP

Altered mentation / HFNC failure
→ Intubation

Medications

  • CHF: Furosemide 40–80 mg IV

  • Pneumonia: CAP/HAP antibiotics

  • COPD: Duonebs + Prednisone 40 mg daily

  • PE: Heparin infusion or DOAC

  • ARDS: No specific medication; treat underlying cause

ICU Triggers

  • FiO₂ >50%

  • HFNC failure

  • Rapidly increasing O₂ requirement

  • Altered mental status

  • Hemodynamic instability

  • Need for intubation

Most Tested Pearls

  • Hypoxemia + hypercapnia → BiPAP

  • Hypoxemia alone → HFNC

  • P/F <300 = ARDS

  • P/F <200 = Moderate ARDS

  • P/F <100 = Severe ARDS

  • A-a gradient ↑ = V/Q mismatch (PE, CHF, ARDS, pneumonia)

One-Line Memory Rules

  • Crackles + BNP ↑ + B-lines → CHF → IV Lasix

  • Fever + infiltrate → Pneumonia → Antibiotics

  • Sudden dyspnea + pleuritic CP → PE → Anticoagulation

  • Absent breath sounds + no lung sliding → PTX → Chest tube

  • Diffuse infiltrates + P/F <300 → ARDS → Lung-protective ventilation

  • SpO₂ <88% despite NRB → HFNC now

  • Increasing O₂ requirement over hours = impending respiratory failure

Labs

  • CBC daily

  • BMP/RFP daily

  • Mg daily

  • LFTs

  • ABG on admission

  • Repeat ABG/VBG q2–4h PRN

  • Procalcitonin

  • Blood cultures x2

  • BNP/NT-proBNP

  • Troponin

  • D-dimer (if PE suspected and low/intermediate risk)

  • Respiratory viral panel

  • Legionella urine antigen

  • Pneumococcal urine antigen

  • Trend fever curve

  • Follow cultures

Imaging

  • CXR

  • CTA Chest if PE suspected

  • CT Chest if diagnosis unclear

  • POCUS (lung/cardiac if available)

  • Echocardiogram

  • EKG

Respiratory Support

Mild Hypoxia

  • Nasal cannula 1–6 L/min

  • Goal SpO2 >90% (or 88–92% if COPD)

Moderate-Severe Hypoxia

  • HFNC

    • Up to 60 L/min

    • FiO2 titrated to oxygen goal

Hypercapnia / COPD / CHF

  • BiPAP

Intubation if

  • SpO2 <88% despite maximal HFNC

  • Worsening respiratory distress

  • Altered mentation

  • Hemodynamic instability

  • Unable to protect airway

Treat Underlying Etiology

Pneumonia

  • Antibiotics per CAP/HAP protocol

CHF/Pulmonary Edema

  • Furosemide 40–80 mg IV

  • Nitroglycerin infusion if BP allows

COPD

  • Duonebs q4h

  • Albuterol q2h PRN

  • Prednisone 40 mg daily

PE

  • Therapeutic anticoagulation

  • Consider thrombolysis if massive PE

Pneumothorax

  • Needle decompression if tension physiology

  • Chest tube placement

Monitoring

  • Telemetry

  • Continuous pulse oximetry

  • Vitals q4h

  • Strict I&O

  • Daily weights

  • Daily CBC/BMP

  • Daily ABG if severe respiratory failure

  • Monitor oxygen requirements closely

ICU Transfer Criteria

  • Progressive hypoxia

  • FiO2 requirement >50%

  • Escalating HFNC/BiPAP requirements

  • Hemodynamic instability

  • Altered mental status

  • Need for intubation

Consults

  • Pulmonology

  • Critical Care

  • Cardiology if CHF suspected

  • Infectious Disease if severe infection

  • PT/OT eval and treat

  • Respiratory Therapy

Nursing

  • HOB 30–45°

  • Continuous pulse ox

  • Aspiration precautions

  • Early mobilization

  • Incentive spirometry

  • Prone positioning if ARDS and appropriate

DVT Prophylaxis

  • Enoxaparin 40 mg SQ daily

OR

  • Heparin 5000 units SQ q8h

GI Prophylaxis

If intubated or critically ill

  • Pantoprazole 40 mg daily

Diet

  • Regular diet if stable

  • NPO if impending intubation

Discharge Checklist

  • Stable oxygen requirement

  • Ambulatory oxygen assessment

  • Home oxygen if SpO2 <88% with exertion

  • Pulmonology follow-up

  • Repeat imaging if indicated

  • Education on return precautions